← Back to Screener
NovaBridge Biosciences American Depositary Shares (NBP)
Price$2.67
Favorite Metrics
Price vs S&P 500 (26W)-52.70%
Price vs S&P 500 (4W)-13.62%
Market Capitalization$299.99M
All Metrics
Book Value / Share (Quarterly)$0.87
Revenue Growth (3Y)-73.83%
Cash Flow / Share (Quarterly)$-0.08
Price vs S&P 500 (YTD)-37.32%
Gross Margin (TTM)100.00%
Net Profit Margin (TTM)-439.76%
EPS (TTM)$-0.19
10-Day Avg Trading Volume0.91M
EPS Excl Extra (TTM)$-0.19
Revenue Growth (5Y)-12.47%
EPS (Annual)$-0.21
ROI (Annual)-20.03%
Gross Margin (Annual)100.00%
Net Profit Margin (5Y Avg)-1791.81%
Cash / Share (Quarterly)$0.79
ROA (Last FY)-17.76%
EBITD / Share (TTM)$-0.43
ROE (5Y Avg)-50.80%
Operating Margin (TTM)-416.50%
Cash Flow / Share (Annual)$-0.08
P/B Ratio1.30x
P/B Ratio (Quarterly)1.98x
Net Income / Employee (Annual)$-1
Net Interest Coverage (TTM)-6.29x
ROA (TTM)-19.41%
EPS Incl Extra (Annual)$-0.21
Current Ratio (Annual)8.09x
Quick Ratio (Quarterly)8.06x
3-Month Avg Trading Volume0.77M
52-Week Price Return172.05%
Revenue / Employee (TTM)$0
P/S Ratio (Annual)10.85x
Asset Turnover (Annual)0.07x
52-Week High$6.79
Operating Margin (5Y Avg)-1670.60%
EPS Excl Extra (Annual)$-0.21
CapEx CAGR (5Y)-75.54%
26-Week Price Return-48.72%
Quick Ratio (Annual)8.06x
13-Week Price Return-30.11%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)8.09x
Enterprise Value$89.36
Revenue / Share Growth (5Y)-18.84%
Asset Turnover (TTM)0.11x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-297.41%
Cash / Share (Annual)$0.79
3-Month Return Std Dev73.64%
Net Income / Employee (TTM)$-1
ROE (Last FY)-20.03%
Net Interest Coverage (Annual)-2.57x
EPS Basic Excl Extra (Annual)$-0.21
Receivables Turnover (TTM)-1.54x
EV / Free Cash Flow (TTM)0.85x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.19
Receivables Turnover (Annual)-1.54x
ROI (TTM)-20.91%
P/S Ratio (TTM)6.34x
Pretax Margin (5Y Avg)-1700.94%
Revenue / Share (Annual)$0.00
Price vs S&P 500 (52W)142.22%
Year-to-Date Return-34.67%
5-Day Price Return7.00%
EPS Normalized (Annual)$-0.21
ROA (5Y Avg)-37.54%
Net Profit Margin (Annual)-751.44%
Month-to-Date Return5.69%
EBITD / Share (Annual)$-0.43
Operating Margin (Annual)-260.52%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-50.69%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.19
P/B Ratio (Annual)1.98x
Pretax Margin (TTM)-439.76%
Book Value / Share (Annual)$0.87
Price vs S&P 500 (13W)-30.80%
Beta1.64x
P/FCF (Annual)0.70x
Revenue / Share (TTM)$0.00
ROE (TTM)-20.91%
52-Week Low$0.69
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
NBPNovaBridge Biosciences American Depositary Shares | 6.34x | — | 100.00% | — | $2.67 |
LLYEli Lilly & Co. | 13.08x | 44.70% | 83.04% | 27.59% | $903.99 |
JNJJohnson & Johnson | 5.94x | 7.87% | 67.95% | 14.90% | $234.54 |
ABBVABBVIE INC. | 6.04x | 8.57% | 71.62% | -2.88% | $208.99 |
MRKMerck & Co., Inc. | 4.41x | 1.31% | 78.55% | 21.23% | $115.46 |
AZNAstraZeneca PLC | 5.28x | 8.63% | 81.31% | 21.88% | $200.47 |
NVSNovartis AG | 4.98x | 8.91% | 75.82% | 15.26% | $149.73 |
NVONovo-Nordisk A/S | 3.62x | 6.43% | 80.98% | 20.66% | $40.93 |
ABTAbbott Laboratories | 3.66x | 6.59% | 56.50% | 8.20% | $95.47 |
PFEPfizer Inc. | 2.47x | -1.64% | 75.81% | -3.51% | $27.22 |
BMYBristol-Myers Squibb Co. | 2.47x | -0.22% | 72.63% | — | $58.96 |
About
NovaBridge Biosciences is a biotechnology company that identifies and develops pharmaceutical assets, combining clinical research with strategic business development to advance therapies toward commercialization. The company's pipeline includes Givastomig, VIS-101, Ragistomig, and Uliledlimab.